Biochemotherapy in patients with advanced vulvovaginal mucosal melanoma

Melanoma Research

Volumn 14, Issue 6, 2004, Pages 517-520

  Harting, Mandy S ^a   Kim, Kevin B ^b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Advanced vulvovaginal melanoma; Biochemotherapy; Mucosal melanoma; Vaginal melanoma; Vulvar melanoma

Indexed keywords

ALPHA INTERFERON; ANTINEOPLASTIC AGENT; CISPLATIN; DACARBAZINE; INTERLEUKIN 2; LACTATE DEHYDROGENASE; TAMOXIFEN; TEMOZOLOMIDE; VINBLASTINE;

ADULT; AGED; ARTICLE; BIOLOGICAL THERAPY; BONE METASTASIS; BRAIN METASTASIS; CANCER CHEMOTHERAPY; CANCER GROWTH; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; KAPLAN MEIER METHOD; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MEDICAL RECORD; MELANOMA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SOFT TISSUE METASTASIS; VAGINA CANCER; VAGINA MUCOSA; VULVA CANCER;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; DACARBAZINE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERFERON-ALPHA; INTERLEUKIN-2; MALE; MEDICAL RECORDS; MELANOMA; MIDDLE AGED; MUCOUS MEMBRANE; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; SURVIVAL RATE; TAMOXIFEN; TREATMENT OUTCOME; VAGINAL NEOPLASMS; VINBLASTINE; VULVAR NEOPLASMS;

EID: 13544270173     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008390-200412000-00012     Document Type: Article

References (23)

1. Raber G, Mempel V, Jackisch C, Hundeiker M, Heinecke A, Kurzl R, et al. Malignant melanoma of the vulva. Report of 89 patients. Cancer 1996; 78:2353-2358.
2. Piura B, Rabinovich A, Yani-Inbar I. Primary malignant melanoma of the vagina: case report and review of literature. Eur J Gynaecol Oncol 2002; 23:195-198.
3. Piura B, Rabinovich A, Dgani R. Malignant melanoma of the vulva: report of six cases and review of the literature. Eur J Gynaecol Oncol 1999; 20:182-186.
4. Verschraegen CF, Benjapibal M, Supakarapongkul W, Levy LB, Ross M, Atkinson EN, et al. Vulvar melanoma at the M.D. Anderson Cancer Center: 25 years later. Int J Gynecol Cancer 2001; 11:359-364.
5. Piura B, Egan M, Lopes A, Monaghan JM. Malignant melanoma of the vulva: a clinicopathologic study of 18 cases. J Surg Oncol 1992; 50:234-240.
6. Rutledge F. Cancer of the vagina. Am J Obstet Gynecol 1967; 97:635-655.
7. Morrow CP, Rutledge FN. Melanoma of the vulva. Obstet Gynecol 1972; 39:745-752.
8. Chung AF, Woodruff JM, Lewis JL, Jr. Malignant melanoma of the vulva: a report of 44 cases. Obstet Gynecol 1975; 45:638-646.
9. Morrow CP, DiSaia PJ. Malignant melanoma of the female genitalia: a clinical analysis. Obstet Gynecol Surv 1976; 31:233-271.
10. Perez CA, Arneson AN, Galakatos A, Samanth HK. Malignant tumors of the vagina. Cancer 1973; 31:36-44.
11. Edington PT, Monaghan JM. Malignant melanoma of the vulva and vagina. Br J Obstet Gynaecol 1980; 87:422-424.
12. Chung AF, Casey MJ, Flannery JT, Woodruff JM, Lewis JL, Jr. Malignant melanoma of the vagina-report of 19 cases. Obstet Gynecol 1980; 55:720-727.
13. Ariel IM. Malignant melanoma of the female genital system: a report of 48 patients and review of the literature. J Surg Oncol 1981; 16: 371-383.
14. Podratz KC, Gaffey TA, Symmonds RE, Johansen KL, O'Brien PC. Melanoma of the vulva: an update. Gynecol Oncol 1983; 16:153-168.
15. Bonner JA, Perez-Tamayo C, Reid GC, Roberts JA, Morley GW. The management of vaginal melanoma. Cancer 1988; 62:2066-2072.
16. Brand E, Fu YS, Lagasse LD, Berek JS. Vulvovaginal melanoma: report of seven cases and literature review. Gynecol Oncol 1989; 33:54-60.
17. Levitan Z, Gordon AN, Kaplan AL, Kaufman RH. Primary malignant melanoma of the vagina: report of four cases and review of the literature. Gynecol Oncol 1989; 33:85-90.
18. Reid GC, Schmidt RW, Roberts JA, Hopkins MP, Barrett RJ, Morley GW. Primary melanoma of the vagina: a clinicopathologic analysis. Obstet Gynecol 1989; 74:190-199.
19. Borazjani G, Prem KA, Okagaki T, Twiggs LB, Adcock LL. Primary malignant melanoma of the vagina: a clinicopathological analysis of 10 cases. Gynecol Oncol 1990; 37:264-267.
20. Van Nostrand KM, Lucci JA, 3rd, Schell M, Berman ML, Manetta A, DiSaia PJ. Primary vaginal melanoma: improved survival with radical pelvic surgery. Gynecol Oncol 1994; 55:234-237.
21. DeMatos P, Tyler D, Seigler HF. Mucosal melanoma of the female genitalia: a clinicopathologic study of forty-three cases at Duke University Medical Center. Surgery 1998; 124:38-48.
22. Tjalma WA, Monaghan JM, de Barros Lopes A, Naik R, Nordin A. Primary vaginal melanoma and long-term survivors. Eur J Gynaecol Oncol 2001; 22:20-22.
23. Piura B, Meirovitz M, Kedar I. Long-term disease-free survival following surgery and active specific immunotherapy with allogeneic vaccine in a patient with high-risk malignant melanoma of the vulva. Eur J Obstet Gynecol Reprod Biol 1998; 81:83-85.